Literature DB >> 8841390

The clinical pharmacology of etoposide: an update.

S Joel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8841390     DOI： 10.1016/s0305-7372(96)90002-x

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  12 in total

1.  Synthesis of novel spin-labeled podophyllotoxin derivatives as potential antineoplastic agents: Part XXV.

Authors:  Liu Yang; Xiang Nan; Wen-Qun Li; Mei-Juan Wang; Xiao-Bo Zhao; Ying-Qian Liu; Zhi-Jun Zhang; Kuo-Hsiung Lee
Journal:  Med Chem Res       Date:  2014-11       Impact factor: 1.965

2.  Metnase mediates chromosome decatenation in acute leukemia cells.

Authors:  Justin Wray; Elizabeth A Williamson; Sheema Sheema; Suk-Hee Lee; Edward Libby; Cheryl L Willman; Jac A Nickoloff; Robert Hromas
Journal:  Blood       Date:  2009-05-20       Impact factor: 22.113

Review 3.  Practical treatment guide for dose individualisation in cancer chemotherapy.

Authors:  P Canal; E Chatelut; S Guichard
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

Review 4.  Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile.

Authors:  Jörg T Hartmann; Hans-Peter Lipp
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

Review 6.  Podophyllotoxin: History, Recent Advances and Future Prospects.

Authors:  Zinnia Shah; Umar Farooq Gohar; Iffat Jamshed; Aamir Mushtaq; Hamid Mukhtar; Muhammad Zia-Ui-Haq; Sebastian Ionut Toma; Rosana Manea; Marius Moga; Bianca Popovici
Journal:  Biomolecules       Date:  2021-04-19

7.  Dose escalation study to evaluate safety, tolerability and efficacy of intravenous etoposide phosphate administration in 27 dogs with multicentric lymphoma.

Authors:  Pierre Boyé; François Serres; Laurent Marescaux; Juliette Hordeaux; Emmanuel Bouchaert; Bruno Gomes; Dominique Tierny
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

8.  Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules.

Authors:  Zhi-Feng Zhao; Kai Wang; Feng-Fu Guo; Hua Lu
Journal:  Med Sci Monit       Date:  2017-03-06

9.  A Phase I/II Study of a 72-h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma.

Authors:  C R Crawley; I R Judson; M Verrill; C Hill; F I Raynaud
Journal:  Sarcoma       Date:  1997

10.  A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours.

Authors:  R T Penson; M V Seiden; U A Matulonis; L J Appleman; A F Fuller; A Goodman; S M Campos; J W Clark; M Roche; J P Eder
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.